DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2237668/myomo-inc-myo-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2237668 Mar 07, 2024 - Myomo, Inc. (MYO) delivered earnings and revenue surprises of -40% and 1.19%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2237650/sight-sciences-inc-sght-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2237650 Mar 07, 2024 - Sight Sciences, Inc. (SGHT) delivered earnings and revenue surprises of 37.14% and 0.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2237604/limoneira-lmnr-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2237604 Mar 07, 2024 - Limoneira (LMNR) delivered earnings and revenue surprises of 37.93% and 1.69%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2237603/oncternal-therapeutics-onct-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2237603 Mar 07, 2024 - Oncternal Therapeutics (ONCT) delivered earnings and revenue surprises of -0.65% and 74.71%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2237601/domo-domo-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2237601 Mar 07, 2024 - Domo (DOMO) delivered earnings and revenue surprises of -66.67% and 0.91%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2237600/traeger-cook-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2237600 Mar 07, 2024 - Traeger (COOK) delivered earnings and revenue surprises of -166.67% and 6.78%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2237596/carparts-com-prts-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2237596 Mar 07, 2024 - CarParts.com (PRTS) delivered earnings and revenue surprises of -10% and 3.85%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/commentary/2237581/hidden-gem-top-ranked-payment-processor-poised-for-a-major-breakout?cid=CS-ZC-FT-investment_ideas-2237581 Mar 07, 2024 - Block has endured a painful two years, but its prospects have turned considerably 0

https://www.zacks.com/commentary/2237496/3-top-rated-mreit-stocks-to-buy-amid-gloomy-backdrop?cid=CS-ZC-FT-industry_outlook-2237496 Mar 07, 2024 - Yield curve inversion, deleveraging efforts, credit spread volatility and spread widening create profitability challenges for the Zacks REIT and Equity Trust industry. Amid this, STWD, ARI and LADR are poised to navigate industry hiccups. 0

https://www.zacks.com/stock/news/2237558/emergent-ebs-down-16-on-q4-earnings-miss-tops-on-sales?cid=CS-ZC-FT-analyst_blog|earnings_article-2237558 Mar 07, 2024 - Emergent (EBS) reports mixed earnings for fourth-quarter 2023. The company signs a forbearance agreement with its lenders, effective till April 2023-end. 0